All living cells are metabolically active.
They produce heat. We measure it.

Simplicity. Specificity. Sensitivity.
And Amazing Speed.

We are Masters of Biocalorimetry.

home-hero
Announcement (84)

Strategic R&D collaboration

Accelerating Therapy ACCESS

Sterility testing is the most time-consuming step in releasing cell therapies. Current methods can take 7–14 days, delaying access to critical treatments.

This collaboration aims to deliver a validated, GMP-compliant test that cuts release time to under 3 days, improving manufacturing efficiency with faster access for patients.

 

IF THERE IS LIFE, THERE IS HEAT

Biocalorimetry

Biocalorimetry measures life through heat. It is versatile and powerful in its simplicity. By detecting metabolic heat from living organisms with high sensitivity, it enables faster results and deeper insights across a wide range of applications and sample types.

We are Masters of the Craft.

Get in touch to explore how biocalorimetry can support your microbial and cell research and testing. .

justerad bild-2

faster release times for cell & gene therapies

Rapid sterility testing

Our biocalorimetry system has the capability to transform rapid sterility testing for advanced therapies. With its seamless, easy workflow, it delivers the fastest detection of living microorganisms. This enables release testing in three days or less. We help developers and clinical labs make significant savings in cost, cut vein-to-vein times and improve patient access.

Contact us to join the innovators shaping the future of rapid microbial testing.

Insights & Resources

Knowledge
Hub

Stay up to date with the latest developments in biocalorimetry and its applications. In our Knowledge Hub you will find news, publications, and insights from Symcel and our partners.

Subscribe to our newsletter to receive the latest updates directly in your inbox.

Work with us

together-kopie

Work with us

Stay up-to-date

WEBINAR

Advancing 3-day sterility testing for cell and gene therapies

Learn about the latest developments in rapid sterility testing for cell and gene therapies.

NEWS

22 October 2025

Symcel receives CEPI grant to accelerate vaccine sterility testing

News

16 SEPTEMBER 2025

Symcel enters into R&D collaboration with Johnson & Johnson to advance rapid sterility testing in cell & gene therapies

News

28 May 2025

New investment boosts Symcel’s development and rollout of rapid sterility testing solutions for advanced therapies

NEWS

4th March 2025

Symcel's calScreener+™ to Power ALS’s New Sterility Testing Services for Cell and Gene Therapy Products

calScreener+ Sterility

calScreener+

Our vision

Knowledge Hub